BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31593321)

  • 1. Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.
    Odejide OO; Uno H; Murillo A; Tulsky JA; Abel GA
    Cancer; 2020 Feb; 126(3):515-522. PubMed ID: 31593321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes.
    Epstein AS; Riley M; Nelson JE; Bernal C; Martin S; Xiao H
    Cancer; 2022 Sep; 128(18):3400-3407. PubMed ID: 35866716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-of-life care for blood cancers: a series of focus groups with hematologic oncologists.
    Odejide OO; Salas Coronado DY; Watts CD; Wright AA; Abel GA
    J Oncol Pract; 2014 Nov; 10(6):e396-403. PubMed ID: 25294393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?
    Kuczmarski TM; Odejide OO
    Curr Hematol Malig Rep; 2021 Apr; 16(2):117-125. PubMed ID: 33864180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actual and Missed Opportunities for End-of-Life Care Discussions With Oncology Patients: A Qualitative Study.
    Knutzen KE; Sacks OA; Brody-Bizar OC; Murray GF; Jain RH; Holdcroft LA; Alam SS; Liu MA; Pollak KI; Tulsky JA; Barnato AE
    JAMA Netw Open; 2021 Jun; 4(6):e2113193. PubMed ID: 34110395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
    Fletcher SA; Cronin AM; Zeidan AM; Odejide OO; Gore SD; Davidoff AJ; Steensma DP; Abel GA
    Cancer; 2016 Apr; 122(8):1209-15. PubMed ID: 26914833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies.
    Pelcovits A; Olszewski AJ; Decker D; Guyer D; Leblanc TW; Egan P
    J Palliat Med; 2022 Apr; 25(4):556-561. PubMed ID: 34842462
    [No Abstract]   [Full Text] [Related]  

  • 8. End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies.
    Egan PC; LeBlanc TW; Olszewski AJ
    Blood Adv; 2020 Aug; 4(15):3606-3614. PubMed ID: 32766855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
    Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
    Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors and Barriers to Goals-of-Care Conversations for Patients With Cancer and Inpatient Mortality.
    Wheless M; Lee JJ; Domenico HJ; Martin BJ; Bennett ML; Martin SF; Berlin J; Green JK; Agarwal R
    JCO Oncol Pract; 2023 Sep; 19(9):767-776. PubMed ID: 37390380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earlier Goals of Care Discussions in Hospitalized Terminally Ill Patients and the Quality of End-of-Life Care: A Retrospective Study.
    Gieniusz M; Nunes R; Saha V; Renson A; Schubert FD; Carey J
    Am J Hosp Palliat Care; 2018 Jan; 35(1):21-27. PubMed ID: 28273751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life Care.
    Shaw B; Parker C; Opat S; Shortt J; Poon P
    J Natl Compr Canc Netw; 2023 Aug; 21(8):813-820.e1. PubMed ID: 37549908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Goals of Care Discussions in Nursing Homes: A Systematic Review.
    Kang JA; Tark A; Estrada LV; Dhingra L; Stone PW
    J Am Med Dir Assoc; 2023 Dec; 24(12):1820-1830. PubMed ID: 37918815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced Cancer.
    Ahluwalia SC; Tisnado DM; Walling AM; Dy SM; Asch SM; Ettner SL; Kim B; Pantoja P; Schreibeis-Baum HC; Lorenz KA
    J Palliat Med; 2015 Oct; 18(10):834-41. PubMed ID: 26186553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to Quality End-of-Life Care for Patients With Blood Cancers.
    Odejide OO; Cronin AM; Condron NB; Fletcher SA; Earle CC; Tulsky JA; Abel GA
    J Clin Oncol; 2016 Sep; 34(26):3126-32. PubMed ID: 27400944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists.
    Habib AR; Cronin AM; Earle CC; Tulsky JA; Mack JW; Abel GA; Odejide OO
    J Palliat Med; 2019 Jun; 22(6):677-684. PubMed ID: 30907686
    [No Abstract]   [Full Text] [Related]  

  • 17. What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network.
    LeBlanc TW; Abernethy AP; Casarett DJ
    J Pain Symptom Manage; 2015 Mar; 49(3):505-12. PubMed ID: 25116911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family Perspectives on Aggressive Cancer Care Near the End of Life.
    Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
    JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Too much, too late: Aggressive measures and the timing of end of life care discussions in women with gynecologic malignancies.
    Zakhour M; LaBrant L; Rimel BJ; Walsh CS; Li AJ; Karlan BY; Cass I
    Gynecol Oncol; 2015 Aug; 138(2):383-7. PubMed ID: 26049124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Among End-of-Life Discussions, Health-Care Utilization, and Costs in Persons With Advanced Cancer: A Systematic Review.
    Starr LT; Ulrich CM; Corey KL; Meghani SH
    Am J Hosp Palliat Care; 2019 Oct; 36(10):913-926. PubMed ID: 31072109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.